1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RELMADA THERAPEUTICS INC
Relmada Therapeutics Inc XNAS: RLMD
1.67 0.08 (5.03%)
474.6K
XNAS Volume

XNAS 15 Sep, 2025 5:30 PM (EDT)

Relmada Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents